Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation

NCT02138136 is registered in ClinicalTrials.gov with Sucampo Pharma Americas, LLC as lead sponsor.

NCT NCT02138136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02138136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Lead sponsor
Sucampo Pharma Americas, LLC
Phase
Phase 3
Overall status
Completed
Start date
February 26, 2014
Completion date
May 1, 2017
Enrollment
419 (actual)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

constipation - functional